Sep 10 |
Update: Teva Pharmaceutical Faces Fine in EU for Dismissive Tactics Against Rivals
|
Sep 10 |
Teva facing EU fine for disparaging Copaxone rival: report
|
Sep 9 |
Cheap Teva Stock Should Reward Patient Investors
|
Sep 6 |
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
|
Sep 5 |
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
|
Aug 26 |
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
Aug 14 |
Teva Pharmaceutical hits a new 52-week high
|
Aug 14 |
Teva's Transformation: From Generics Leader To Branded Drug Innovator
|
Aug 5 |
Teva Pharmaceutical Industries Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Aug 2 |
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
|